Wellington Management Group
CATX icon

Wellington Management Group’s Perspective Therapeutics CATX Stock Holding History

Wellington Management Group’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Sell
67,445
-100,778
-60% -$381K ﹤0.01% 1885
2026
Q1 		$701K Buy
+168,223
New +$711K ﹤0.01% 1736
2025
Q4 		– Sell
-206,632
Closed -$709K – 1942
2025
Q3 		$709K Buy
+206,632
New +$753K ﹤0.01% 1838

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Wellington Management Group's CATX Position: Q2 2026 in Review

Wellington Management Group reduced its Perspective Therapeutics (CATX) stake by 60% in Q2 2026, selling an estimated $381K and leaving 67,445 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #1885.

Wellington Management Group first reported a position in CATX in Q3 2025 and has held it in 3 quarters since. The position peaked at $709K in Q3 2025. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Wellington Management Group held 67,445 shares of Perspective Therapeutics worth $230K as of Q2 2026.
  • Wellington Management Group sold 100,778 Perspective Therapeutics shares in Q2 2026, an estimated $381K.
  • Perspective Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1885 holding.
  • Wellington Management Group first reported a position in Perspective Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Wellington Management Group's Perspective Therapeutics position peaked at $709K in Q3 2025.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.